Literature DB >> 14615930

What is wrong with the 30-year-old practice of scalp cooling for the prevention of chemotherapy-induced hair loss?

Wim P M Breed1.   

Abstract

Since about 1970 scalp cooling has been used to prevent chemotherapy-induced hair loss, one of the most common and emotionally distressing side effects of cancer therapy. Generally accepted opinions, uncertainty and controversy, topics to study and recommendations for improving the results of scalp cooling are the subjects of this article which was also presented at the MASCC Symposium, June 2003, Berlin.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14615930     DOI： 10.1007/s00520-003-0551-8

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN： 0941-4355            Impact factor:   3.603


  3 in total

1.  Hypothermia postpones DNA damage repair in irradiated cells and protects against cell killing.

Authors:  Brandon J Baird; Jennifer S Dickey; Asako J Nakamura; Christophe E Redon; Palak Parekh; Yuri V Griko; Khaled Aziz; Alexandros G Georgakilas; William M Bonner; Olga A Martin
Journal:  Mutat Res       Date:  2010-12-24       Impact factor: 2.433

2.  Efficacy and tolerability of two scalp cooling systems for the prevention of alopecia associated with docetaxel treatment.

Authors:  Daniel C Betticher; Geoffrey Delmore; Urs Breitenstein; Sandro Anchisi; Beatrice Zimmerli-Schwab; Andreas Müller; Roger von Moos; Anne Marguerite Hügli-Dayer; Hubert Schefer; Sereina Bodenmann; Vera Bühler; Ralph R Trueb
Journal:  Support Care Cancer       Date:  2013-05-02       Impact factor: 3.603

3.  Determination of the most effective cooling temperature for the prevention of chemotherapy-induced alopecia.

Authors:  Eva M Ekwall; Lisa M L Nygren; Anders O Gustafsson; Bengt G Sorbe
Journal:  Mol Clin Oncol       Date:  2013-09-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.